Scientific article
Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay
ContributorsShi, Liu; Westwood, Sarah; Baird, Alison L; Winchester, Laura; Dobricic, Valerija; Kilpert, Fabian; Hong, Shengjun; Franke, Andre; Hye, Abdul; Ashton, Nicholas J; Morgan, Angharad R; Bos, Isabelle; Vos, Stephanie J B; Buckley, Noel J; Kate, Mara Ten; Scheltens, Philip; Vandenberghe, Rik; Gabel, Silvy; Meersmans, Karen; Engelborghs, Sebastiaan; De Roeck, Ellen E; Sleegers, Kristel; Frisoni, Giovanni; Blin, Olivier; Richardson, Jill C; Bordet, Régis; Molinuevo, José L; Rami, Lorena; Wallin, Anders; Kettunen, Petronella; Tsolaki, Magda; Verhey, Frans; Lleó, Alberto; Alcolea, Daniel; Popp, Julius; Peyratout, Gwendoline; Martinez-Lage, Pablo; Tainta, Mikel; Johannsen, Peter; Teunissen, Charlotte E; Freund-Levi, Yvonne; Frölich, Lutz; Legido-Quigley, Cristina; Barkhof, Frederik; Blennow, Kaj; Zetterberg, Henrik; Baker, Susan; Morgan, B Paul; Streffer, Johannes; Visser, Pieter Jelle; Bertram, Lars; Lovestone, Simon; Nevado-Holgado, Alejo J
Published inAlzheimer's & Dementia, vol. 15, no. 11, p. 1478-1488
Publication date2019
Abstract
Keywords
- Amyloid β
- Causal relationship
- Plasma proteomics
- Replication
- SOMAscan assay
- Tau.
Affiliation entities
Research groups
Funding
- European Commission - European Medical Information Framework [115372]
Citation (ISO format)
SHI, Liu et al. Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay. In: Alzheimer’s & Dementia, 2019, vol. 15, n° 11, p. 1478–1488. doi: 10.1016/j.jalz.2019.06.4951
Main files (1)
Article (Published version)
Identifiers
- PID : unige:140834
- DOI : 10.1016/j.jalz.2019.06.4951
- PMID : 31495601
Additional URL for this publicationhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880298/
Journal ISSN1552-5260
